佛慈制药(002644.SZ)发布前三季度业绩，归母净利润3808.24万元，同比下降2.54%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating income of 624 million yuan, representing a year-on-year decrease of 11.92% [1] - The net profit attributable to shareholders of the listed company was 38.08 million yuan, down 2.54% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 23.81 million yuan, reflecting a year-on-year decline of 5.45% [1]